Literature DB >> 16371235

Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library.

Xiaoli Yu1, Donald H Gilden, Alanna M Ritchie, Mark P Burgoon, Kathryne M Keays, Gregory P Owens.   

Abstract

We generated recombinant antibodies (rAbs) from over-represented IgG sequences expressed by single plasma cells from multiple sclerosis (MS) cerebrospinal fluid (CSF). Panning of a phage-displayed random peptide library with the rAbs revealed several specific peptide sequences. Inhibition assays confirmed specific binding of the peptides to the antigen-binding site of the antibody. The native IgG of MS CSF from which the recombinant antibody was cloned also recognized these peptides. Our data demonstrate that MS rAb reflects the specificity of IgG in the CSF. Thus, the epitopes/mimotopes identified by MS rAb may provide clues to disease-relevant antigens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371235     DOI: 10.1016/j.jneuroim.2005.11.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  21 in total

Review 1.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

2.  Identification of peptide targets in neuromyelitis optica.

Authors:  Xiaoli Yu; Miyoko Green; Don Gilden; Chiwah Lam; Katherine Bautista; Jeffrey L Bennett
Journal:  J Neuroimmunol       Date:  2011-05-28       Impact factor: 3.478

3.  Recombinant antibodies generated from both clonal and less abundant plasma cell immunoglobulin G sequences in subacute sclerosing panencephalitis brain are directed against measles virus.

Authors:  Mark P Burgoon; Yupanqui A Caldas; Kathryne M Keays; Xiaoli Yu; Donald H Gilden; Gregory P Owens
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

4.  Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.

Authors:  Xiaoli Yu; Don Gilden; Laura Schambers; Olga Barmina; Mark Burgoon; Jeffrey Bennett; Greg Owens
Journal:  J Neuroimmunol       Date:  2010-12-21       Impact factor: 3.478

5.  Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.

Authors:  Jeffrey L Bennett; Chiwah Lam; Sudhakar Reddy Kalluri; Philippe Saikali; Katherine Bautista; Cecily Dupree; Magdalena Glogowska; David Case; Jack P Antel; Gregory P Owens; Don Gilden; Stefan Nessler; Christine Stadelmann; Bernhard Hemmer
Journal:  Ann Neurol       Date:  2009-11       Impact factor: 10.422

6.  Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.

Authors:  Doris Lambracht-Washington; Kevin C O'Connor; Elizabeth M Cameron; Andrea Jowdry; E Sally Ward; Elliot Frohman; Michael K Racke; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2007-04-23       Impact factor: 3.478

7.  Identification of measles virus epitopes using an ultra-fast method of panning phage-displayed random peptide libraries.

Authors:  Xiaoli Yu; Olga Barmina; Mark Burgoon; Don Gilden
Journal:  J Virol Methods       Date:  2009-01-03       Impact factor: 2.014

8.  Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis.

Authors:  Mark P Burgoon; Randall J Cohrs; Jeffrey L Bennett; Sarah W Anderson; Alanna M Ritchie; Sabine Cepok; Bernhard Hemmer; Don Gilden; Gregory P Owens
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

9.  Characterization of phage peptide interaction with antibody using phage mediated immuno-PCR.

Authors:  Xiaoli Yu; Mark P Burgoon; Andrew J Shearer; Donald H Gilden
Journal:  J Immunol Methods       Date:  2007-07-18       Impact factor: 2.303

10.  Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF.

Authors:  G P Owens; A M Ritchie; D H Gilden; M P Burgoon; D Becker; J L Bennett
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.